Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
3.20
Dollar change
-0.10
Percentage change
-3.03
%
IndexRUT P/E- EPS (ttm)-15.65 Insider Own4.12% Shs Outstand50.10M Perf Week18.08%
Market Cap166.02M Forward P/E5.61 EPS next Y0.57 Insider Trans0.00% Shs Float49.75M Perf Month74.86%
Income-795.70M PEG- EPS next Q1.67 Inst Own79.36% Short Float23.19% Perf Quarter54.59%
Sales1.10B P/S0.15 EPS this Y-114.35% Inst Trans-1.91% Short Ratio4.02 Perf Half Y-27.60%
Book/sh13.46 P/B0.24 EPS next Y111.92% ROA-33.14% Short Interest11.54M Perf Year-77.14%
Cash/sh1.69 P/C1.89 EPS next 5Y- ROE-74.14% 52W Range1.42 - 13.67 Perf YTD33.33%
Dividend Est.- P/FCF- EPS past 5Y- ROI-68.59% 52W High-76.59% Beta1.21
Dividend TTM- Quick Ratio0.54 Sales past 5Y14.76% Gross Margin27.82% 52W Low125.35% ATR (14)0.34
Dividend Ex-Date- Current Ratio1.07 EPS Y/Y TTM-2007.56% Oper. Margin-17.62% RSI (14)72.96 Volatility18.17% 15.68%
Employees2500 Debt/Eq1.26 Sales Y/Y TTM-27.04% Profit Margin-72.06% Recom1.00 Target Price5.50
Option/ShortYes / Yes LT Debt/Eq0.66 EPS Q/Q-235.19% Payout- Rel Volume1.60 Prev Close3.30
Sales Surprise13.93% EPS Surprise-136.41% Sales Q/Q12.71% EarningsNov 08 AMC Avg Volume2.87M Price3.20
SMA2065.03% SMA5053.60% SMA200-26.80% Trades Volume4,591,818 Change-3.03%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Underweight
Aug-29-23Downgrade The Benchmark Company Buy → Hold
Apr-10-23Upgrade The Benchmark Company Hold → Buy $22
Mar-17-23Downgrade JP Morgan Neutral → Underweight $23 → $9
Nov-10-22Downgrade The Benchmark Company Buy → Hold
Apr-29-22Downgrade Cantor Fitzgerald Overweight → Neutral
Jan-20-22Upgrade The Benchmark Company Hold → Buy $77
Nov-08-21Downgrade The Benchmark Company Buy → Hold
May-05-21Downgrade Argus Buy → Hold
Apr-07-21Initiated The Benchmark Company Buy $150
Feb-21-24 03:24PM
07:35AM
07:06AM
07:00AM
Jan-17-24 11:55AM
02:20PM Loading…
Jan-12-24 02:20PM
Jan-11-24 08:00AM
Jan-09-24 07:30AM
Dec-12-23 06:53AM
Dec-11-23 10:05AM
09:03AM
Nov-29-23 11:56AM
Nov-28-23 06:59AM
Nov-24-23 07:30AM
Nov-09-23 01:19PM
11:00PM Loading…
Nov-08-23 11:00PM
05:38PM
Oct-30-23 04:45PM
Oct-19-23 06:30AM
Oct-16-23 07:00AM
Oct-02-23 07:00AM
Sep-07-23 11:30AM
Aug-30-23 05:59AM
Aug-29-23 09:37AM
Aug-25-23 11:36AM
Aug-23-23 12:33PM
Aug-22-23 11:42AM
Aug-21-23 06:00PM
Aug-17-23 09:57AM
09:35AM
09:35AM Loading…
Aug-16-23 09:35AM
Aug-09-23 09:26AM
08:29AM
12:30AM
Aug-08-23 07:40PM
06:29PM
04:31PM
08:23AM
07:50AM
07:44AM
07:15AM
Aug-07-23 11:32AM
Aug-04-23 09:21AM
Aug-01-23 12:06PM
Jul-31-23 04:05PM
Jul-25-23 06:30AM
Jul-20-23 06:31PM
06:15PM
06:03PM
Jun-27-23 05:30PM
08:02AM
07:55AM
Jun-26-23 05:30AM
Jun-21-23 08:00PM
11:30AM
Jun-09-23 08:20AM
Jun-08-23 11:30AM
Jun-07-23 08:20AM
Jun-05-23 09:39AM
May-17-23 06:21AM
May-15-23 06:27PM
07:58AM
May-11-23 06:30AM
May-10-23 10:47AM
08:53AM
07:48AM
03:00AM
May-09-23 06:15PM
04:05PM
May-08-23 09:29AM
May-02-23 10:01AM
Apr-26-23 08:00PM
Apr-24-23 02:09AM
Apr-20-23 11:41AM
Apr-19-23 04:05PM
09:00AM
Apr-10-23 01:00PM
Mar-30-23 11:56AM
07:44AM
Mar-29-23 03:50PM
12:37PM
11:30AM
11:01AM
09:48AM
09:26AM
09:02AM
08:52AM
08:42AM
Mar-17-23 11:16AM
Mar-10-23 06:56AM
Mar-01-23 05:32AM
Feb-28-23 04:51PM
12:05PM
09:55AM
09:22AM
Feb-27-23 10:00PM
06:55PM
04:42PM
Feb-23-23 10:00AM
Feb-20-23 10:00AM
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zoon Kathryn CDirectorJun 02Sale8.351,83015,28049,971Jul 24 08:28 AM
Zoon Kathryn CDirectorMay 25Sale8.381,70014,24651,801Jul 24 08:28 AM